Cargando…

Next‐generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia

BACKGROUND: Atypical chronic myeloid leukemia (aCML) is a hematologic disorder characterized by leukocytosis with increased dysplastic neutrophils and their precursors. In CSF3R gene, the activation mutation including T618I is frequently reported in aCML but is rarely accompanied by truncation mutat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Jae Won, Yoon, Jung, Jung, Chul Won, Lee, Ki‐O, Kim, Jong Won, Kim, Sun‐Hee, Kim, Hee‐Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031557/ https://www.ncbi.nlm.nih.gov/pubmed/31692115 http://dx.doi.org/10.1002/jcla.23064

Ejemplares similares

Clonal dominance of a donor‐derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)
por: Yoon, Jung, et al.
Publicado: (2019)

A Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia
por: Kim, Hyun Woo, et al.
Publicado: (2006)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations
por: Shin, Sang-Yong, et al.
Publicado: (2016)

Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia
por: Kim, Borahm, et al.
Publicado: (2020)

LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31
por: Yoon, Jung, et al.
Publicado: (2021)

Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia
por: Kim, Seon Young, et al.
Publicado: (2023)

Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors
por: Jang, Hyeok-Jae, et al.
Publicado: (2021)

Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies
por: Kim, Heyjin, et al.
Publicado: (2019)

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia
por: Park, Jong-Ho, et al.
Publicado: (2018)

The First Case of Acute Myeloid Leukemia With t(10;11)(p13;q21);PICALM-MLLT10 Rearrangement Presenting With Extensive Skin Involvement
por: Park, Min-Seung, et al.
Publicado: (2023)

FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
por: Lee, Jong-Mi, et al.
Publicado: (2022)

BRAF V600E and MAP2K1 Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma Cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
por: Kim, Jin Ju, et al.
Publicado: (2023)

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
por: Kim, Dae Sik, et al.
Publicado: (2016)

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia
por: Ahn, Seo-Yeon, et al.
Publicado: (2023)

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype
por: Ahn, Jae-Sook, et al.
Publicado: (2017)

Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Kim, Hee-Je, et al.
Publicado: (2021)

Genomics of Acute Myeloid Leukemia: The Next Generation
por: Riva, Laura, et al.
Publicado: (2012)

Principles of Genetic Counseling in the Era of Next-Generation Sequencing
por: Yang, Mina, et al.
Publicado: (2018)

Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey
por: Uhm, Jieun, et al.
Publicado: (2021)

Implications of the 5(th) Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia
por: Lee, Cheonghwa, et al.
Publicado: (2023)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms
por: Kim, Borahm, et al.
Publicado: (2019)

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
por: Kim, Hyun-Young, et al.
Publicado: (2018)

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
por: Ahn, Jae-Sook, et al.
Publicado: (2016)

Comparison of Next-Generation Sequencing and Fluorescence In Situ Hybridization for Detection of Segmental Chromosomal Aberrations in Neuroblastoma
por: Kim, Eojin, et al.
Publicado: (2021)

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations
por: Choi, Yoon Ji, et al.
Publicado: (2022)

Recent advances in recording and modulation technologies for next-generation neural interfaces
por: Hong, Ji-Won, et al.
Publicado: (2021)

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Augments Acute Lung Injury via Its Neutrophil Priming Effects
por: Choi, Jae Chol, et al.
Publicado: (2008)

A multicenter, retrospective analysis of elderly patients with acute myeloid leukemia who were treated with decitabine
por: Yi, Jun Ho, et al.
Publicado: (2018)

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2022)

Diagnostic Accuracy of Cerebrospinal Fluid (CSF) Cytology in Metastatic Tumors: An Analysis of Consecutive CSF Samples
por: Bae, Yoon Sung, et al.
Publicado: (2013)

A Case of Next-generation Sequencing Gene Testing: Points to be Considered in Testing and Reporting
por: Kim, Na-Kyoung, et al.
Publicado: (2022)

Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019)

Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data
por: Youk, Jeonghwan, et al.
Publicado: (2016)

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
por: Ahn, Seo-Yeon, et al.
Publicado: (2022)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing
por: Park, Hee Sue, et al.
Publicado: (2022)

A case of synchronous multiple myeloma and chronic myeloid leukemia
por: Lee, Ji-Young, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sqg0qchsictsdv0u7vlfuvm821